INFRASTRUCTURAL CAPABILITY OF INVESTIGATOR-INITIATED TRIALS INVOLVING UNAPPROVED INVESTIGATIONAL DRUGS IN JAPAN

被引：0
|
作者：
Shimizu, T. [1 ]
Kaneda, H. [1 ]
Tsurutani, J. [1 ]
Okamoto, K. [1 ]
Tanaka, K. [1 ]
Ohnishi, R. [1 ]
Nomura, M. [1 ]
Aida, H.
Hashii, C.
Nakagawa, K. [1 ]
机构：
[1] Kinki Univ, Fac Med, Dept Med Oncol, Higashiosaka, Osaka 577, Japan
来源：
ANNALS OF ONCOLOGY | 2013年 / 24卷
关键词：
D O I：
10.1093/annonc/mdt452.2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] NIH MULTICENTER INVESTIGATOR-INITIATED TRIALS - AN ENDANGERED SPECIES
    MEINERT, CL
    CONTROLLED CLINICAL TRIALS, 1988, 9 (02): : 97 - 102
  • [22] INFRASTRUCTURE DEVELOPMENT OF INVESTIGATOR-INITIATED CLINICAL TRIALS AT A FRONT-LINE REGIONAL HOSPITAL IN JAPAN
    Takeda, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 69 - 69
  • [23] The value proposition of investigator-initiated clinical trials conducted by networks
    Tate, Rhiannon
    Britton, Emma
    Webb, Steve
    Ramage, Charlotte
    Bernhardt, Julie
    Cass, Alan
    French, Craig J.
    Groom, Katie
    Herkes, Robert
    Katz, Catherine
    Mol, Ben W.
    Simes, R. John
    Sonderlund, Neil
    Butcher, Belinda E.
    Zalcberg, John R.
    MEDICAL JOURNAL OF AUSTRALIA, 2021, 214 (04) : 159 - +
  • [24] Development, Review, and Activation of Thoracic Oncology Investigator-Initiated Trials
    Gerber, David E.
    Wynters, Claire R.
    Prasad, Tanushree
    Schnel, Ronny K.
    Zhang, Song
    Stinchcombe, Thomas E.
    Villaruz, Liza C.
    Bauml, Joshua M.
    Iams, Wade T.
    Patil, Tejas
    Liu, Stephen V.
    Horn, Leora
    Hudak, John M.
    Camidge, D. Ross
    CLINICAL CANCER RESEARCH, 2025, 31 (06) : 1103 - 1108
  • [25] Challenges for Academic Investigator-Initiated Pediatric Trials for Rare Diseases
    Ahmed, Raees
    Duerr, Ulrike
    Gavenis, Karsten
    Hilgers, Reinhard
    Gross, Oliver
    CLINICAL THERAPEUTICS, 2014, 36 (02) : 184 - 190
  • [26] Serious adverse event reporting in investigator-initiated clinical trials
    Wallace, Sophie
    Myles, Paul S.
    Zeps, Nikolajs
    Zalcberg, John R.
    MEDICAL JOURNAL OF AUSTRALIA, 2016, 204 (06) : 231 - +
  • [27] Investigational medicinal products, related costs and hospital pharmacy services for investigator-initiated trials: A mixed-methods study
    Heravi, Ala Taji
    Henn, Anne
    Deuster, Stefanie
    McLennan, Stuart
    Gloy, Viktoria
    Mitter, Vera Ruth
    Briel, Matthias
    Yunusa, Ismaeel
    PLOS ONE, 2022, 17 (03):
  • [28] Comparison of investigator-initiated and industry-initiated trials in Canada and other countries.
    Wong, Bryan
    North, Scott A.
    Ben Tran
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [29] Investigator-Initiated IBD Trials in the United States: Facts, Obstacles, and Answers
    Herfarth, Hans H.
    Jackson, Susan
    Schliebe, Barbara G.
    Martin, Christopher
    Ivanova, Anastasia
    Anton, Kristen
    Sandler, Robert S.
    Long, Millie D.
    Isaacs, Kim L.
    Osterman, Mark T.
    Sands, Bruce E.
    Higgins, Peter D.
    Lewis, James D.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 (01) : 14 - 22
  • [30] Protocol-writing support conferences for investigator-initiated clinical trials
    Goto, Masaya
    Muragaki, Yoshihiro
    Aruga, Atsushi
    OPEN ACCESS JOURNAL OF CLINICAL TRIALS, 2016, 8 : 7 - 12
12345